Products & Reviews

Manufactured under strict Good Manufacturing Practice guidelines, these proteins are designed for use in preclinical, clinical, and therapeutic applications where quality and regulatory compliance are paramount.

Monoclonal and polyclonal antibodies with validated performance for the precise detection of disease biomarkers in a wide range of clinical and research immunoassays.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.